Skip to main content

Closed

INTS: Intensity Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

2thpctl

Volume

1.94×avg

Market Cap

11.22MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Intensity Therapeutics, Inc.

INTSNASDAQ Capital Market·USD·Closed

Intensity Therapeutics, Inc.

INTSNASDAQ·USD·Closed

$4.15

+2.47%

$4.15

+$0.10 (2.47%)

52W Range

2thpctl

Volume

1.94×avg

Mkt Cap

11.22MUSD

P/E

-0.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings